news
02-23-2023, 12:10 PM
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A | NEJM (https://news.google.com/rss/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjIxMTA3NdIBAA?oc=5) nejm.org
Hemophilia A Gene Therapy Durable at 2 Years; Under FDA Review (https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aW NsZS85ODg1ODXSAQA?oc=5) Medscape
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B | NEJM (https://news.google.com/rss/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjIxMTY0NNIBAA?oc=5) nejm.org
Hemophilia A Gene Therapy — Some Answers, More Questions | NEJM (https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTWUyMjEyMzQ30gEA?oc=5) nejm.org
Etranacogene Dezaparvovec for Hemophilia B | NEJM (https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5lam0ub3JnL2RvLzEwLjEwNTYvTk VKTWRvMDA2OTIwL2Z1bGwv0gEA?oc=5) nejm.org
More... (https://news.google.com/rss/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjIxMTA3NdIBAA?oc=5)
Hemophilia A Gene Therapy Durable at 2 Years; Under FDA Review (https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aW NsZS85ODg1ODXSAQA?oc=5) Medscape
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B | NEJM (https://news.google.com/rss/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjIxMTY0NNIBAA?oc=5) nejm.org
Hemophilia A Gene Therapy — Some Answers, More Questions | NEJM (https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTWUyMjEyMzQ30gEA?oc=5) nejm.org
Etranacogene Dezaparvovec for Hemophilia B | NEJM (https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5lam0ub3JnL2RvLzEwLjEwNTYvTk VKTWRvMDA2OTIwL2Z1bGwv0gEA?oc=5) nejm.org
More... (https://news.google.com/rss/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjIxMTA3NdIBAA?oc=5)